×
IVF Information

News Center

Current position: Blessed Future > IVF Information >

IVF Journey in the United States for International Patients: What to Prepare Before Visiting Clinics in New York and California

Release time: 2026-11-16 Blessed Future

For most international patients, an IVF trip to New York or California works as a single visit only when three things are locked in before booking flights: your stimulation start date can be aligned with your travel dates through birth-control-pill scheduling, your home-country lab work meets the clinic's acceptance rules, and your transfer plan matches how long you can actually stay. When any one of these slips, the journey splits into two trips, and the second flight is rarely optional.

One Trip or Two? The Buffer Days That Decide Your Flight Plan

International patients usually plan around the wrong variable. They ask whether a clinic is "good for one-trip patients," when the real question is how many uncompressible days sit between the first day of a menstrual period and the day the return flight lands. That window is fixed by biology, and no clinic can shorten it.

Here is how the days stack up. A baseline ultrasound and bloodwork must happen on day 2 to day 4 of the cycle, before any stimulation medication starts, because the ovaries need to be confirmed quiet. Ovarian stimulation then runs roughly 8 to 12 days, with monitoring visits every 1 to 3 days. The trigger shot comes next, and egg retrieval follows about 36 hours after it. From period day 1 to retrieval, the shortest realistic span is around 10 to 14 days, and it can stretch longer if follicles grow slowly. Add 2 to 3 days of recovery after retrieval, and a patient doing a fresh transfer should plan for a stay of 3 to 4 weeks from arrival to departure.

The fragile point is at the front of this chain. If your period arrives five days later than expected, retrieval shifts five days later, and a return ticket booked for the original date suddenly sits in the middle of your stimulation. Airlines charge change fees plus fare differences, and during holiday seasons the fare difference alone can exceed what a fully flexible ticket would have cost in the first place. Patients who book fixed-date economy tickets to save a few hundred dollars routinely pay more to move them later.

This is exactly where oral contraceptive priming changes the math. Taking combined oral contraceptives from day 1 to day 3 of a natural period and continuing for roughly 10 to 25 days suppresses the ovaries, and the withdrawal bleed that follows the last active pill functions as a predictable "day 1." The clinic counts backward from your intended arrival date and sets the pill stop date so that your baseline scan falls 2 to 3 days after you land. In effect, your cycle start moves from something your body decides to something your itinerary decides. A patient flying from East Asia to Los Angeles, for example, can stop pills on a Thursday, expect a withdrawal bleed within about 3 days, present for baseline ultrasound the following Monday, and start stimulation that same week, with retrieval landing inside a pre-booked 3-week window.

Three boundary conditions deserve attention. First, pill priming only works with protocols the clinic actually offers; natural-cycle and minimal-stimulation protocols track your own ovulation and generally cannot be scheduled this way. Second, in poor responders, some physicians avoid extended suppression because it can blunt an already weak ovarian response, so ask specifically whether your ovarian reserve profile makes you a suitable candidate. Third, a minority of clinics allow the first 4 to 5 days of stimulation monitoring at a partner clinic in your home country, with travel around day 5 of stimulation; this shortens the US stay to roughly 10 to 14 days, but it depends entirely on that clinic's policy and on the quality of the local monitoring lab, so confirm it in writing before assuming it exists.

Why Do Home-Country Lab Results Get Rejected Before You Even Fly?

The remote pre-visit stage looks simple on a clinic website: complete some blood tests at home, upload the reports, attend a video consultation. The trap hides in one word on most clinic checklists, "accredited," and patients discover its meaning only after landing.

US fertility clinics operate under federal rules that shape which lab reports they can rely on. Clinical laboratories performing testing on human specimens in the United States must hold certification under the Clinical Laboratory Improvement Amendments of 1988, regulated through 42 CFR Part 493. When a clinic accepts outside results, it typically requires that the testing lab hold CLIA certification or an equivalent international accreditation such as ISO 15189, that reports be in English or accompanied by a certified translation, and that results fall inside a recency window. In practice, anti-M??llerian hormone (AMH) and thyroid or prolactin results are commonly accepted if drawn within the past 6 to 12 months, while infectious disease screening (HIV, hepatitis B and C, syphilis) often carries a shorter window, sometimes 90 days at clinics that follow stricter internal policy. Reproductive tissue handling also falls under FDA rules at 21 CFR Part 1271, which is why communicable disease screening is treated with particular seriousness. Exact windows vary by clinic and state, so treat every number here as a question to ask, not an assumption to fly on.

Consider a concrete failure pattern. A patient completes AMH, TSH, and a full infectious panel at a well-regarded hospital in her home country, has the reports translated, uploads them, and books a single 3-week trip. On arrival, the clinic's review finds that the hospital lab holds only a domestic accreditation with no CLIA or ISO 15189 equivalent, and that the infectious panel was drawn 7 months ago when the clinic requires 90 days. The result: everything gets redrawn in the clinic's own lab, adding 2 to 3 days of waiting for results before stimulation can start. Depending on the panel, repeat testing commonly runs from several hundred to over a thousand dollars, and the fixed return ticket now sits two weeks too early. The one-trip budget assumption collapses at the front desk on day 1.

The preventive step costs one email. Before the video consultation, ask the clinic coordinator, in writing, for four items: the exact list of tests required for both partners, the accreditation standard your home lab must hold, the recency window for each test, and whether the clinic will pre-review scanned reports and confirm acceptance before you purchase tickets. Clinics that regularly serve international patients, such as New Hope Fertility Center in Manhattan or HRC Fertility's Southern California locations, generally have a defined remote-intake process for this; clinics without one are telling you something about how much friction to expect.

One more detail patients overlook: carrier screening. Some clinics request genetic carrier screening (for conditions such as cystic fibrosis or spinal muscular atrophy) for at least one partner, and these panels must be performed by specific US-based laboratories the clinic works with. Home-country results often cannot substitute, because the clinic's embryology and genetics workflow depends on reports from labs it has contractual relationships with. Ask whether this applies to you before assuming your local genetic report transfers.

What Happens Between Egg Retrieval and Embryo Transfer, and How Does It Change Your Stay?

The retrieval-to-transfer interval is where trip plans quietly double. The choice between a fresh transfer and a frozen transfer is not primarily a medical preference you express; it follows from whether embryos undergo genetic testing and how your body responds to stimulation.

A fresh transfer, placed 3 to 5 days after retrieval, keeps everything inside one trip, but it is available only when the clinic clears you: estrogen levels must not suggest elevated ovarian hyperstimulation syndrome risk, and no preimplantation genetic testing (PGT) can be involved, because biopsied embryos need results before they can be selected. If PGT is planned, embryos are biopsied on day 5 to 7 after retrieval, and results typically return in 1 to 2 weeks. Almost no international patient waits that out in a Manhattan or San Francisco hotel. The standard pattern becomes two trips: fly home after retrieval, wait for results, then return for a frozen embryo transfer in a subsequent cycle, which adds roughly 4 to 6 weeks of interval at minimum. A patient who assumed one trip of 3 weeks and chose PGT should expect either two transpacific flights or a single stay of 6 to 8 weeks.

Even an elective freeze without PGT produces the same split, since frozen transfers are usually scheduled in a cycle after the retrieval cycle. The practical consequence shows up in accommodation strategy. Book refundable lodging for the retrieval phase, because retrieval dates drift by 2 to 3 days in either direction as follicles grow. For the transfer phase, dates are far more predictable once the cycle is medicated, so non-refundable rates become acceptable there. Reversing that order is a common and expensive mistake.

Does the Male Partner's Schedule Count as a Separate Trip?

It can, and patients often fail to plan for it. A semen sample is needed on the day of retrieval, and clinic requirements typically specify 2 to 5 days of abstinence beforehand. If the male partner cannot remain in the US for the full stimulation phase, two alternatives exist, each with trade-offs. He can visit the clinic during an earlier window, produce a sample, and have it frozen for use on retrieval day; this converts his role into a short standalone visit of one or two days, at the cost of cryostorage fees. Some clinics also accept frozen samples shipped from a laboratory in the home country, though acceptance depends on the clinic's shipping and thaw protocols, and this must be arranged weeks in advance. What rarely works is assuming he can simply fly in on retrieval day itself, because jet lag, illness, or a failed same-day sample leaves no second chance within that cycle. Discuss the fallback plan with the clinic before booking either partner's tickets.

How Do New York and California Clinics Pace International Patients Differently?

Clinics in both states serve large international volumes, but their scheduling models differ in ways that directly affect your flight count. The single most consequential difference: some programs require the new-patient consultation, physical examination, and treatment-plan sign-off to happen in person one full cycle before stimulation begins. Under that model, a patient who hoped for one trip actually makes three flights: visit one for consultation and planning, visit two for stimulation and retrieval, visit three for transfer. Other clinics complete the consultation by video, review remote labs in advance, and compress everything else, allowing a single visit for retrieval and, when applicable, a second for transfer.

New York's international patient infrastructure reflects Manhattan's logistics. Programs such as RMA's New York locations and New Hope Fertility Center handle steady international flow and have built remote-intake workflows around it, including telehealth consultations and coordination of remote lab review. The trade-off is cost of stay: accommodation in Manhattan runs high across a 3-week monitoring phase with visits every 1 to 3 days, so patients often choose lodging within walking distance of the clinic to control both budget and daily friction. Time zones matter too; a patient in East Asia reaches a Manhattan clinic's morning appointments in her own evening, which makes video follow-ups workable, while a California clinic's morning slots fall in the middle of her night.

California's geography produces a different pattern. HRC Fertility operates multiple locations across Southern California, and programs in the Bay Area such as Spring Fertility in San Francisco and Oakland regularly coordinate with traveling patients. Patients combining treatment with an extended stay sometimes prefer California for the wider choice of neighborhoods and the possibility of monitoring at one location while consulting with physicians across a network. The scheduling questions remain identical regardless of state: does the clinic require an in-person consult a full cycle ahead, does it accept your home-country labs, and does it offer pill-priming to align your cycle with your flights? Ask all three before comparing anything else.

Published outcomes for any clinic you shortlist can be checked independently through the CDC's Assisted Reproductive Technology reports and the SART (Society for Assisted Reproductive Technology) clinic summaries, which publish per-clinic cycle data. Use those sources rather than clinic marketing pages, and remember that published success rates reflect each clinic's patient mix as much as its laboratory performance.

Which Clinics in New York and California Work Smoothly with International Patients?

Three programs illustrate the range of models available, and none of the details below should replace direct confirmation with the clinic.

Clinic Location Profile for international patients
New Hope Fertility Center Manhattan, New York Long experience receiving patients traveling from abroad, with workflows that include telehealth consultation and remote review of preliminary testing; offers both minimal-stimulation and conventional protocols, which affects whether pill-priming scheduling is available.
HRC Fertility Multiple locations, Southern California A multi-site network accustomed to coordinating travel timing, monitoring, and lab work across locations, which can ease scheduling when a stay needs to compress around fixed flight dates.
Spring Fertility San Francisco and Oakland, Bay Area Serves a substantial international and tech-industry patient base; patients weighing a Bay Area stay can compare two nearby monitoring locations when planning accommodation around daily visits.

When comparing any of these programs, published per-clinic data on the CDC and SART platforms, plus a written answer to the three scheduling questions above, will tell you more than a single consultation call. Treatment protocols, laboratory techniques, fee schedules, and consent paperwork all vary by clinic and change over time, so confirm current details directly with each program before committing to flights.

What Should You Prepare, in What Order, Before Booking Anything?

The sequence matters more than the checklist itself. Request the clinic's written international-patient requirements first, including test lists, accreditation standards, and recency windows. Complete home-country testing only at a lab whose accreditation you have confirmed against that list, and have the clinic pre-review scanned reports before any ticket is purchased. Ask explicitly whether an in-person consultation is required one cycle before stimulation, because that answer alone determines whether your plan is one trip, two trips, or three. If your dates are rigid, ask whether oral contraceptive priming is appropriate for your ovarian reserve and chosen protocol, and get the pill stop-date logic explained in calendar terms. Finally, plan the male partner's contribution with the same seriousness as the female partner's cycle, including a frozen-sample fallback arranged in advance.

Patients who lock down these four variables before purchasing a single ticket almost always keep their trip count to the minimum their medical plan allows. Patients who book flights first and ask these questions after landing supply the anecdotes that circulate in expat forums about budgets that doubled mid-treatment. The difference between the two groups rarely involves medicine; it involves calendar control and one carefully worded email sent before departure.

Contact Us